1-4 of 4
Helen Evans
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT073: A first-in-human study of oral TNO155 (batoprotafib) alone and in combination with EGF816 (nazartinib) in adult patients with advanced solid tumors

Free
Chia-Chi Lin, Helena Yu, Dong-Wan Kim, Daniel Tan, Dae Ho Lee, Maria Jove Casulleras, N Steeghs, Fredericus Eskens, Ahmad A. Tarhini, Melissa Johnson, Irene Brana, Giuseppe Curigliano, Lillian Siu, Aitana Calvo Ferrandiz, Geoffrey Shapiro, Victor Moreno Garcia, Hironobu Minami, Martin Klumpp, Helen Evans, Thomas Hengelage, Suresh B. Lakshminarayana, John Ritz, Xin Yang, David Kodack, Christopher Straub, Pruthvi Desireddy, Susan Moody, Pilar Garrido
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_2): CT073.
https://doi.org/10.1158/1538-7445.AM2025-CT073
Published: 25 April 2025
View article titled, Abstract CT073: A first-in-human study of oral TNO155 (batoprotafib) alone and in combination with EGF816 (nazartinib) in adult patients with advanced solid tumors
Journal Articles

The anti-vascular properties of a novel thioredoxin inhibitor with anti-tubulin properties

Free
Helen Evans, Gillian Tozer, Simon Akerman, Sheila Harris, Matthew Fisher, Leigh Williams, Chryso Kanthou, Andrew Westwell, Poulam Patel, Stewart Martin
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 379.
Published: 01 May 2008
View article titled, The anti-vascular properties of a novel thioredoxin inhibitor with anti-tubulin properties
Journal Articles

Targeting the thioredoxin system for breast cancer treatment

Free
Lei Zhang, Kelly Huber, Helen Evans, Abhik Mukherjee, Paulam Patel, Stewart Martin
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 642.
Published: 01 May 2007
View article titled, Targeting the thioredoxin system for breast cancer treatment
Journal Articles

Phase I Trial of Temozolomide Using an Extended Continuous Oral Schedule

Free
Cathryn S. Brock, Edward S. Newlands, Steven R. Wedge, Mark Bower, Helen Evans, Iain Colquhoun, Mary Roddie, Mark Glaser, Maureen H. Brampton, Gordon J. S. Rustin
Journal: Cancer Research
Cancer Res (1998) 58 (19): 4363–4367.
Published: 01 October 1998
View article titled, Phase I Trial of Temozolomide Using an Extended Continuous Oral Schedule
Open the PDF for Phase I Trial of Temozolomide Using an Extended Continuous Oral Schedule in another window